Candel Therapeutics (CADL) Debt Ratio (2020 - 2025)

Candel Therapeutics (CADL) has 6 years of Debt Ratio data on file, last reported at 0.01 in Q4 2025.

• For the quarter ending Q4 2025, Debt Ratio fell 92.6% year-over-year to 0.01; the trailing twelve-month figure through Dec 2025 stood at 0.01 (down 92.6% YoY), and the FY2025 full-year result was 0.01, down 92.6% from the prior year.
• Debt Ratio fell to 0.01 in Q4 2025, from 0.06 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.62 in Q2 2024 to a low of 0.01 in Q3 2021.
• A 5-year average of 0.2 and a median of 0.11 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio soared 5444.22% in 2023 and tumbled 92.6% in 2025, its largest moves.
• Tracing CADL's Debt Ratio over 5 years: stood at 0.01 in 2021, then surged by 4042.14% to 0.26 in 2022, then declined by 9.98% to 0.23 in 2023, then tumbled by 53.51% to 0.11 in 2024, then plunged by 92.6% to 0.01 in 2025.
• Business Quant data shows CADL's Debt Ratio at 0.01 in Q4 2025, 0.06 in Q3 2025, and 0.06 in Q2 2025.